Add to ORKGAdvanced cholangiocarcinoma continues to harbor a difficult prognosis and therapeutic options have been limited. During the course of a clinical trial of whole genomic sequencing seeking druggable targets, we examined six patients with advanced cholangiocarcinoma. Integrated genome-wide and whole transcriptome sequence analyses were performed o
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Cholangiocarcinoma is one of the epithelial cancers with the poorest prognosis and the narrowest the...
Although rare, intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malig...
BACKGROUND & AIMS: Cholangiocarcinoma is a heterogeneous disease with a poor outcome that accounts f...
Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinic...
Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinic...
Cholangiocarcinoma (CCA), a deadly malignancy of the bile ducts, can be classified based on its anat...
Cholangiocarcinoma (CCA), a deadly malignancy of the bile ducts, can be classified based on its anat...
Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor prognosis and li...
The modern concept of therapy for intrahepatic cholangiocarcinoma including surgical treatment, must...
Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor prognosis and li...
Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features of cholan...
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Cholangiocarcinoma is one of the epithelial cancers with the poorest prognosis and the narrowest the...
Although rare, intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malig...
BACKGROUND & AIMS: Cholangiocarcinoma is a heterogeneous disease with a poor outcome that accounts f...
Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinic...
Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinic...
Cholangiocarcinoma (CCA), a deadly malignancy of the bile ducts, can be classified based on its anat...
Cholangiocarcinoma (CCA), a deadly malignancy of the bile ducts, can be classified based on its anat...
Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor prognosis and li...
The modern concept of therapy for intrahepatic cholangiocarcinoma including surgical treatment, must...
Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor prognosis and li...
Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features of cholan...
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Intrahepatic cholangiocarcinoma (iCCA) is an anatomically and biologically distinct entity with a ri...
Cholangiocarcinoma is one of the epithelial cancers with the poorest prognosis and the narrowest the...
Although rare, intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malig...